Milano S, Simon C, Grélot L
Département de Physiologie et de Neurophysiologie, CNRS URA 205, Faculté des Sciences et Techniques Saint Jérôme, Marseille, France.
Clin Auton Res. 1991 Dec;1(4):275-80. doi: 10.1007/BF01819832.
We have studied the peripheral mechanisms responsible for the severe vomiting observed in cisplatin treated cats. Release of 5-hydroxytryptamine from isolated portions of the ileum and ileal tissue concentrations of 5-hydroxytryptamine were studied in vitro with control animals and animals previously treated with cisplatin. In the latter, two groups were observed: animals in which cisplatin (single dose, 10 mg/kg) induced vomiting within 4 h and animals that did not vomit within 4 h. Spectrofluorimetric assessment of 5-hydroxytryptamine in the perfusate and ileal tissue revealed that cisplatin increases both release, and tissue levels, of ileal 5-hydroxytryptamine in animals which vomited, whereas only ileal 5-hydroxytryptamine release was increased in animals which did not vomit. This may have clinical implications as cisplatin induced emesis may be more effectively prevented by drugs preventing ileal 5-hydroxytryptamine formation rather than release.
我们研究了顺铂治疗的猫出现严重呕吐的外周机制。在体外,对对照组动物和先前用顺铂治疗过的动物,研究了从回肠分离部分释放5-羟色胺以及回肠组织中5-羟色胺的浓度。在后者中,观察到两组:顺铂(单剂量,10mg/kg)在4小时内引起呕吐的动物和在4小时内未呕吐的动物。对灌注液和回肠组织中5-羟色胺的荧光分光光度评估显示,顺铂增加了呕吐动物回肠5-羟色胺的释放和组织水平,而在未呕吐的动物中仅回肠5-羟色胺释放增加。这可能具有临床意义,因为预防顺铂引起的呕吐可能用阻止回肠5-羟色胺形成的药物比阻止其释放的药物更有效。